Cytophage Technologies Ltd.

TSXV:CYTO Stock Report

Market Cap: CA$16.5m

Cytophage Technologies Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

TSXV:CYTO Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
27 Sep 24BuyCA$2,900Julius KalcevichIndividual10,000CA$0.29
06 May 24BuyCA$17,000Julius KalcevichIndividual50,000CA$0.34
18 Apr 24BuyCA$1,600Harold WolkinIndividual4,000CA$0.40
17 Apr 24BuyCA$16,500William OllerheadIndividual44,000CA$0.37
16 Apr 24SellCA$7,788William OllerheadIndividual22,000CA$0.35
12 Apr 24BuyCA$2,760Harold WolkinIndividual6,000CA$0.46
22 Mar 24BuyCA$6,142William OllerheadIndividual13,500CA$0.45
18 Mar 24BuyCA$6,960William OllerheadIndividual14,500CA$0.48
15 Mar 24BuyCA$12,876William OllerheadIndividual26,826CA$0.48
14 Mar 24BuyCA$1,882Harold WolkinIndividual3,900CA$0.48
07 Mar 24BuyCA$1,495Harold WolkinIndividual3,000CA$0.50
15 Feb 24BuyCA$6,775Michael GrahamIndividual15,500CA$0.45
15 Feb 24BuyCA$25,557William OllerheadIndividual56,500CA$0.51
13 Feb 24BuyCA$2,500Michael GrahamIndividual5,000CA$0.50

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CYTO?
Owner TypeNumber of SharesOwnership Percentage
Institutions1,119,5702.08%
Individual Insiders6,756,25512.5%
General Public46,059,39685.4%

Dilution of Shares: Insufficient data to determine if shareholders have been diluted in the past year.

Top Shareholders

Top 9 shareholders own 14.6% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.27%
Steven Theriault
5,000,000CA$1.5m0%no data
1.61%
Ollerhead Capital
868,570CA$264.9k0%no data
1.11%
Harold Wolkin
599,400CA$182.8k0%no data
0.9%
William Ollerhead
482,728CA$147.2k0%no data
0.83%
Heather Medwick
450,000CA$137.2k0%no data
0.47%
Princeville Capital
251,000CA$76.6k0%no data
0.19%
Robert Gabor
100,000CA$30.5k0%no data
0.16%
Julius Kalcevich
84,127CA$25.7k13.5%no data
0.074%
Shantha Kodihalli
40,000CA$12.2k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 15:42
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cytophage Technologies Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution